Capping enzyme of flavivirus and utilization of this protein in a process to test drugs with antiviral properties
US6949353B2 · kind B2 · utility
1Cited by
0References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 31, 2002 |
| Grant date | Sep 27, 2005 |
| Priority date | — |
| Expiry date | May 31, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/14
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
This invention concerns an isolated and purified polypeptide capable of acting as a guanylyltransferase and methyltransferase comprising capping enzyme of flavivirus (CEF). The invention also concerns the use of such polypeptide to identify biologically active molecule wich can be used in the treatment or the prevention of diseases resulting from Flavivirus infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.